Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study
<h4>Background</h4> <p>Artemisinins, the most effective antimalarials available, are not recommended for falciparum malaria during the first trimester due to safety concerns. Therefore, quinine is used despite poor efficacy. Assessing artemisinin safety requires weighing the risks...
Auteurs principaux: | Moore, K, Simpson, J, Paw, M, Pimanpanarak, M, Wiladphaingern, J, Rijken, M, Jittamala, P, White, N, Fowkes, F, Nosten, F, McGready, R |
---|---|
Format: | Journal article |
Publié: |
Elsevier
2016
|
Documents similaires
-
Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission.
par: Moore, K, et autres
Publié: (2017) -
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: A population-based study
par: McGready, R, et autres
Publié: (2012) -
Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester
par: Harrington, WE, et autres
Publié: (2021) -
Quantifying low birth weight, preterm birth and small-for-gestational-age effects of malaria in pregnancy: a population cohort study.
par: Rijken, M, et autres
Publié: (2014) -
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.
par: Mcgready, R, et autres
Publié: (2012)